Transcriptional repressor ZEB2 promotes terminal differentiation of CD8(+) effector and memory T cell populations during infection

KD Omilusik, JA Best, BF Yu, S Goossens, A Weidemann, JV Nguyen, E Seuntjens, A Stryjewska, C Zweier, R Roychoudhuri, L Gattinoni, LM Bird, Y Higashi, H Kondoh, Danny Huylebroeck, J Haigh, AW Goldrath

Research output: Contribution to journalArticleAcademicpeer-review

143 Citations (Scopus)


ZEB2 is a multi-zinc-finger transcription factor known to play a significant role in early neurogenesis and in epithelial-mesenchymal transition-dependent tumor metastasis. Although the function of ZEB2 in T lymphocytes is unknown, activity of the closely related family member ZEB1 has been implicated in lymphocyte development. Here, we find that ZEB2 expression is up-regulated by activated T cells, specifically in the KLRG1(hi) effector CD8(+) T cell subset. Loss of ZEB2 expression results in a significant loss of antigen-specific CD8(+) T cells after primary and secondary infection with a severe impairment in the generation of the KLRG1(hi) effector memory cell population. We show that ZEB2, which can bind DNA at tandem, consensus E-box sites, regulates gene expression of several E-protein targets and may directly repress Il7r and Il2 in CD8(+) T cells responding to infection. Furthermore, we find that T-bet binds to highly conserved T-box sites in the Zeb2 gene and that T-bet and ZEB2 regulate similar gene expression programs in effector T cells, suggesting that T-bet acts upstream and through regulation of ZEB2. Collectively, we place ZEB2 in a larger transcriptional network that is responsible for the balance between terminal differentiation and formation of memory CD8(+) T cells.
Original languageUndefined/Unknown
Pages (from-to)2027-2039
Number of pages13
JournalJournal of Experimental Medicine
Issue number12
Publication statusPublished - 2015

Research programs

  • EMC MGC-02-13-02

Cite this